Internal Medicine, Hematology & Oncology · S Weymouth, MA
NPI
1215093968
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
541 Main St, Suite 414
S Weymouth, MA, 02190
Phone (781) 952-1650
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
1,064 services
Medicare patients, 2024
560
Average age 76
Drug cost, 2024
$4.7M
1,636 prescriptions
Company payments, 2025
$43.25
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meredith Faggen was code 99213 (office e&m - established), 475 times for 353 patients. In total Meredith Faggen billed 1,064 services in 16 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 475 | 353 | $48.90 | $23K |
| 99214 Office E&M - Established | Office | 419 | 244 | $74.20 | $31K |
| 99215 Office E&M - Established | Office | 100 | 65 | $115.36 | $12K |
| 99204 Office E&M - New | Office | 19 | 19 | $111.65 | $2,121 |
| 99222 Hospital E&M - Initial | Facility | 15 | 15 | $108.91 | $1,634 |
| 99232 Hospital E&M - Subsequent | Facility | 15 | 12 | $65.75 | $986 |
By year: 2022 $80K for 1,101 services; 2023 $66K for 987 services; 2024 $72K for 1,064 services.
Medicare prescription drug claims, 2024
In 2024, the drug Meredith Faggen prescribed most often to Medicare patients was Letrozole, with 213 prescriptions and refills. In total Meredith Faggen wrote 1,636 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 213 | 501 | 74 | $4,663 |
| Tamoxifen Citrate Generic | 107 | 250 | 35 | $2,454 |
| Anastrozole Generic | 81 | 208 | 34 | $1,759 |
| Gabapentin Generic | 74 | 94 | 19 | $1,309 |
| Lorazepam Generic | 71 | 71 | 23 | $268 |
| Exemestane Generic | 60 | 133 | 23 | $17K |
| Oxycodone Hcl Generic | 52 | 52 | 23 | $513 |
| Eliquis Apixaban | 45 | 69 | 14 | $39K |
| Revlimid Lenalidomide | 44 | 44 | 15 | $550K |
| Potassium Chloride Generic | 39 | 67 | 13 | $557 |
| Abiraterone Acetate Generic | 36 | 36 | 14 | $77K |
| Dexamethasone Generic | 31 | 33 | 19 | $609 |
| Verzenio Abemaciclib | 30 | 30 | Under 11 | $443K |
| Ondansetron Hcl Generic | 28 | 28 | 23 | $468 |
| Hydroxyurea Generic | 27 | 68 | Under 11 | $813 |
Brand drugs: 363 claims; generic drugs: 1,273 claims; opioid claims: 115.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meredith Faggen $43.25 ($43.25 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $43.25.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $43.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.